Shanghai Jiaoda Onlly Co., Ltd.

Shanghai Jiaoda Onlly Co., a small-cap pharmaceutical company, saw a notable increase in its stock performance, reaching an intraday high. Over the past month, it has significantly outperformed the China Shanghai Composite. Despite these gains, the company faces challenges with management efficiency and profitability metrics.

Shanghai Jiaoda Onlly Co. faced a notable stock decline of 9.64% on May 21, 2026, amid a challenging trading environment. Despite a strong monthly performance with a 32.05% increase, the company has struggled year-to-date and over the past year, reflecting ongoing profitability challenges.

Shanghai Jiaoda Onlly Co. experienced a decline on October 30, 2025, contrasting with the overall market's modest gain. Despite recent setbacks, the company has shown strong annual growth and consistent profitability over the past four quarters, although its management efficiency could improve.